SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-042072
Filing Date
2018-06-25
Accepted
2018-06-25 17:05:31
Documents
3
Period of Report
2018-06-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-16018_18k.htm 8-K 26517
2 EX-99.1 a18-16018_1ex99d1.htm EX-99.1 14426
3 GRAPHIC g160181mmi001.jpg GRAPHIC 5429
  Complete submission text file 0001104659-18-042072.txt   49846
Mailing Address 2530 MERIDIAN PARKWAY SUITE 300 DURHAM NC 27713
Business Address 2530 MERIDIAN PARKWAY SUITE 300 DURHAM NC 27713 919-806-4487
Dova Pharmaceuticals, Inc. (Filer) CIK: 0001685071 (see all company filings)

IRS No.: 813858961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38135 | Film No.: 18917632
SIC: 2834 Pharmaceutical Preparations